EMBO Workshop — A 20/20 vision of the future of nuclear receptors

Nuclear receptors (NRs) constitute the only reliably druggable class of transcription factors, thereby functioning as both key downstream cellular effectors and direct drug targets. Despite numerous therapeutic innovations and treatments, much remains unknown about the biological processes under the control of NR activity. This EMBO 2022 Workshop on a 20/20 vision of the future of NRs and their role in precision medicine, aims to exploit this unique position of the field (i.e. long track record of singular achievements having high impact in diverse fields of research, remarkable clinical relevance and being at the vanguard of technical and methodological advances) to showcase the future of this important field and to highlight recent advances that will form the basis for the future treatments, diagnostic assays and for assessing the latest innovations. The field is at a critical juncture, and whilst this meeting will continue the very successful EMBO NR conference series, the EMBO 2022 workshop will have a different twist on the theme. The objective of this workshop is to discuss NRs and the role they play, specifically in the future of medicine and medical research, with this meeting functioning as the dawn of the next era for NR biology and medicine.